PROSTATE CANCER DETECTION AT LOW PROSTATE SPECIFIC ANTIGEN
- 1 March 2000
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam)International Journal of Cancer, 1999
- Cancer Surveillance Series: Interpreting Trends in Prostate Cancer Part I: Evidence of the Effects of Screening in Recent Prostate Cancer Incidence, Mortality, and Survival RatesJNCI Journal of the National Cancer Institute, 1999
- Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam Region)The Prostate, 1999
- Evaluation of prostate‐specific antigen, digital rectal examination and transrectal ultrasonography in population‐based screening for prostate cancer: improving the efficiency of early detectionBritish Journal of Urology, 1997
- The Free-to-Total Serum Prostate Specific Antigen Ratio for Staging Prostate CarcinomaJournal of Urology, 1997
- Cancer statistics, 1997CA: A Cancer Journal for Clinicians, 1997
- Prospective Evaluation Plan for Randomised Trials of Prostate Cancer ScreeningJournal of Medical Screening, 1996
- The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA densityUrology, 1995
- The value of screening tests in the detection of prostate cancer. Part I: Results of a retrospective evaluation of 1726 menUrology, 1995
- Ethics of a prostate cancer screening trialThe Lancet, 1994